Sun Pharmaceutical Recalls Vecuronium Bromide Due to Glass Particulates
Sun Pharmaceutical Industries is recalling Vecuronium Bromide for Injection because glass particles were detected in the product.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA classified this as a Class I recall, which meets the rubric criteria for a Critical severity score.
Plain-English summary
Sun Pharmaceutical Industries, Inc. is recalling Vecuronium Bromide for Injection, 10 mg vials, due to the presence of particulate matter. The foreign matter identified in the product is glass.
The recall affects 12,534 cartons and 125,340 vials of the medication. The specific lots involved are JKS0443A, JKS0444A, and JKS0477A, all with an expiration date of 03/2019. The product was distributed nationwide in the United States.
Healthcare providers and patients should stop using the affected lots of Vecuronium Bromide for Injection. The FDA has classified this as a Class I recall, which is the most serious type of recall.
The recalled product
- Product
- VECURONIUM BROMIDE (VECURONIUM BROMIDE)
- Brand
- VECURONIUM BROMIDE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Category
- Drug — Injection
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: JKS0443A
- JKS0444A
- JKS0477A
- EXP 03/2019
UPCs (1)
- 0347335932447
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Sun Pharmaceutical Industries, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · VECURONIUM BROMIDE
- SevereSun Pharmaceutical Recalls Vecuronium Bromide Injection Due to Glass Particles
FDA (Drugs) · 2019-01-16
Same manufacturer · Sun Pharmaceutical Industries, Inc.
See all →- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- SevereDoxorubicin liposome injection vials contain glass particulate matter
FDA (Drugs) · 2026-06-17
Same hazard · glass particulate
See all →- SevereTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighProgesterone Injection Recalled for Glass Particulate Matter in Vials
FDA (Drugs) · 2024-08-07
- HighCyanocobalamin Injection Vials Recalled for Glass Particulate Contamination
FDA (Drugs) · 2024-07-24
- HighEye and Ear Dropper Recalled for Potential Glass Particulate Contamination
FDA (Devices) · 2023-06-21